{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T11:08:57Z","timestamp":1768561737878,"version":"3.49.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T00:00:00Z","timestamp":1671494400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Respir Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Bronchiectasis is characterized by neutrophilic inflammation and frequent exacerbations often associated with infections. Lipid mediators play critical roles in the inflammatory response, and the balance between anti-inflammatory and pro-inflammatory mediators could drive to chronic inflammation. The aim of this study was to evaluate the metabolites of docosahexaenoic acid and arachidonic acid in sputum of adults with bronchiectasis defining their associations with clinical data, bacterial load and neutrophil elastase.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>An observational, cross-sectional study was conducted at the bronchiectasis program of the Policlinico Hospital in Milan, Italy, where patients were enrolled. Active neutrophil elastase was measured by enzyme-linked immunosorbent assay, pro-resolving and pro-inflammatory fatty acid-derived mediators were evaluated by mass spectrometry and respiratory pathogens were assessed by real-time PCR. Analysis were performed on sputum collected during stable state and clinical data were also collected.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Levels of pro-inflammatory mediators derived from arachidonic acid metabolism showed association with neutrophil elastase, were proportional to <jats:italic>Pseudomonas aeruginosa<\/jats:italic> identifications and were linked with radiological gravity index, while the concentrations of pro-resolution mediators derived from docosahexaenoic acid were associated with a better health status, highlighted by the inverse correlation with radiological gravity index, bacterial infections and sputum volume production.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>Pro-inflammatory mediators derived from FA metabolisms are associated with severity of bronchiectasis while DHA-derived metabolites are inversely associated with severity of the disease, which may be used for personized treatment of bronchiectasis.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12931-022-02301-5","type":"journal-article","created":{"date-parts":[[2022,12,20]],"date-time":"2022-12-20T08:02:49Z","timestamp":1671523369000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Pro-resolving and pro-inflammatory fatty acid-derived mediators in sputum of stable state bronchiectasis patients"],"prefix":"10.1186","volume":"23","author":[{"given":"Leonardo","family":"Terranova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrizia","family":"Ris\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Gramegna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Pinna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlo","family":"Agostoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie-Louise","family":"Syr\u00e9n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Turolo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Marchisio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Amati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Aliberti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angelo","family":"Sala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Blasi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,12,20]]},"reference":[{"key":"2301_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017","author":"E Polverino","year":"2017","unstructured":"Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. Eur Respir J. 2017. https:\/\/doi.org\/10.1183\/13993003.00629-2017.","journal-title":"Eur Respir J"},{"key":"2301_CR2","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0055-2019","author":"F Amati","year":"2019","unstructured":"Amati F, Simonetta E, Gramegna A, et al. The biology of pulmonary exacerbations in bronchiectasis. Eur Respir Rev. 2019. https:\/\/doi.org\/10.1183\/16000617.0055-2019.","journal-title":"Eur Respir Rev"},{"key":"2301_CR3","first-page":"6","volume":"147","author":"PJ Cole","year":"1986","unstructured":"Cole PJ. Inflammation: a two-edged sword\u2013the model of bronchiectasis. Eur J Respir Dis Suppl. 1986;147:6\u201315.","journal-title":"Eur J Respir Dis Suppl"},{"key":"2301_CR4","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2018-212895","author":"O Sibila","year":"2019","unstructured":"Sibila O, Perea L, Cant\u00f3 E, et al. Antimicrobial peptides, disease severity and exacerbations in bronchiectasis. Thorax. 2019. https:\/\/doi.org\/10.1136\/thoraxjnl-2018-212895.","journal-title":"Thorax"},{"key":"2301_CR5","doi-asserted-by":"publisher","DOI":"10.1186\/s12931-017-0691-x","author":"A Gramegna","year":"2017","unstructured":"Gramegna A, Amati F, Terranova L, et al. Neutrophil elastase in bronchiectasis. Respir Res. 2017. https:\/\/doi.org\/10.1186\/s12931-017-0691-x.","journal-title":"Respir Res"},{"key":"2301_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.plefa.2007.10.009","author":"MR Al-Turkmani","year":"2007","unstructured":"Al-Turkmani MR, Freedman SD, Laposata M. Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis. Prostaglandins Leukot Essent Fatty Acids. 2007. https:\/\/doi.org\/10.1016\/j.plefa.2007.10.009.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"2301_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/nature05877","author":"JM Schwab","year":"2007","unstructured":"Schwab JM, Chiang N, Arita M, et al. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature. 2007. https:\/\/doi.org\/10.1038\/nature05877.","journal-title":"Nature"},{"key":"2301_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbalip.2014.08.006","author":"CN Serhan","year":"2015","unstructured":"Serhan CN, Dalli J, Colas RA, et al. Protectins and maresins: new pro-resolving families of mediators in acute inflammation and resolution bioactive metabolome. Biochim Biophys Acta. 2015. https:\/\/doi.org\/10.1016\/j.bbalip.2014.08.006.","journal-title":"Biochim Biophys Acta"},{"key":"2301_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2020.100894","author":"CN Serhan","year":"2020","unstructured":"Serhan CN, Gupta SK, Perretti M, et al. The Atlas of Inflammation Resolution (AIR). Mol Aspects Med. 2020. https:\/\/doi.org\/10.1016\/j.mam.2020.100894.","journal-title":"Mol Aspects Med"},{"key":"2301_CR10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI97943","author":"CN Serhan","year":"2018","unstructured":"Serhan CN, Levy BD. Resolvins in inflammation: emergence of the pro-resolving superfamily of mediators. J Clin Invest. 2018. https:\/\/doi.org\/10.1172\/JCI97943.","journal-title":"J Clin Invest"},{"key":"2301_CR11","doi-asserted-by":"publisher","DOI":"10.1186\/s40248-018-0166-z","author":"M Oriano","year":"2019","unstructured":"Oriano M, Terranova L, Teri A, et al. Comparison of different conditions for DNA extraction in sputum\u2014a pilot study. Multidiscip Respir Med. 2019. https:\/\/doi.org\/10.1186\/s40248-018-0166-z.","journal-title":"Multidiscip Respir Med"},{"key":"2301_CR12","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19103256","author":"L Terranova","year":"2018","unstructured":"Terranova L, Oriano M, Teri A, et al. How to process sputum samples and extract bacterial DNA for microbiota analysis. Int J Mol Sci. 2018. https:\/\/doi.org\/10.3390\/ijms19103256.","journal-title":"Int J Mol Sci"},{"key":"2301_CR13","doi-asserted-by":"publisher","DOI":"10.1016\/j.pupt.2019.101856","author":"M Oriano","year":"2019","unstructured":"Oriano M, Terranova L, Sotgiu G, et al. Evaluation of active neutrophil elastase in sputum of bronchiectasis and cystic fibrosis patients: a comparison among different techniques. Pulm Pharmacol Ther. 2019. https:\/\/doi.org\/10.1016\/j.pupt.2019.101856.","journal-title":"Pulm Pharmacol Ther"},{"key":"2301_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmi.2015.05.004","author":"NJ Gadsby","year":"2015","unstructured":"Gadsby NJ, McHugh MP, Russell CD, et al. Development of two real-time multiplex PCR assays for the detection and quantification of eight key bacterial pathogens in lower respiratory tract infections. Clin Microbiol Infect. 2015. https:\/\/doi.org\/10.1016\/j.cmi.2015.05.004.","journal-title":"Clin Microbiol Infect"},{"key":"2301_CR15","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.43.7.3221-3226.2005","author":"S Yang","year":"2005","unstructured":"Yang S, Lin S, Khalil A, et al. Quantitative PCR assay using sputum samples for rapid diagnosis of pneumococcal pneumonia in adult emergency department patients. J Clin Microbiol. 2005. https:\/\/doi.org\/10.1128\/JCM.43.7.3221-3226.2005.","journal-title":"J Clin Microbiol"},{"key":"2301_CR16","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201605-1027OC","author":"JD Chalmers","year":"2017","unstructured":"Chalmers JD, Moffitt KL, Suarez-Cuartin G, et al. Neutrophil elastase activity is associated with exacerbations and lung function decline in bronchiectasis. Am J Respir Crit Care Med. 2017. https:\/\/doi.org\/10.1164\/rccm.201605-1027OC.","journal-title":"Am J Respir Crit Care Med"},{"key":"2301_CR17","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00252-2018","author":"HR Keir","year":"2019","unstructured":"Keir HR, Fong CJ, Crichton ML, et al. Personalised anti-inflammatory therapy for bronchiectasis and cystic fibrosis: selecting patients for controlled trials of neutrophil elastase inhibition. ERJ Open Res. 2019. https:\/\/doi.org\/10.1183\/23120541.00252-2018.","journal-title":"ERJ Open Res"},{"key":"2301_CR18","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00769-2020","author":"M Oriano","year":"2020","unstructured":"Oriano M, Gramegna A, Terranova L, et al. Sputum neutrophil elastase associates with microbiota and Pseudomonas aeruginosa in bronchiectasis. Eur Respir J. 2020. https:\/\/doi.org\/10.1183\/13993003.00769-2020.","journal-title":"Eur Respir J"},{"key":"2301_CR19","doi-asserted-by":"publisher","DOI":"10.1126\/science.6301011","author":"B Samuelsson","year":"1983","unstructured":"Samuelsson B. Leukotrienes: mediators of immediate hypersensitivity reactions and inflammation. Science. 1983. https:\/\/doi.org\/10.1126\/science.6301011.","journal-title":"Science"},{"key":"2301_CR20","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2020-216475","author":"P Bedi","year":"2021","unstructured":"Bedi P, Ziegler K, Whitfield PD, et al. Dysregulation of prostaglandins, leukotrienes and lipoxin A 4 in bronchiectasis. Thorax. 2021. https:\/\/doi.org\/10.1136\/thoraxjnl-2020-216475.","journal-title":"Thorax"},{"key":"2301_CR21","doi-asserted-by":"publisher","DOI":"10.1042\/EBC20190083","author":"PC Calder","year":"2020","unstructured":"Calder PC. Eicosanoids. Essays Biochem. 2020. https:\/\/doi.org\/10.1042\/EBC20190083.","journal-title":"Essays Biochem"},{"key":"2301_CR22","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2015.03.083","author":"M Romano","year":"2015","unstructured":"Romano M, Cianci E, Simiele F, et al. Lipoxins and aspirin-triggered lipoxins in resolution of inflammation. Eur J Pharmacol. 2015. https:\/\/doi.org\/10.1016\/j.ejphar.2015.03.083.","journal-title":"Eur J Pharmacol"},{"key":"2301_CR23","first-page":"1","volume":"5","author":"E Granstr\u00f6m","year":"1978","unstructured":"Granstr\u00f6m E, Samuelsson B. Quantitative measurement of prostaglandins and thromboxanes: general considerations. Adv Prostaglandin Thromboxane Res. 1978;5:1\u201313.","journal-title":"Adv Prostaglandin Thromboxane Res"},{"key":"2301_CR24","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.47.070178.005025","author":"B Samuelsson","year":"1978","unstructured":"Samuelsson B, Goldyne M, Granstrom E, et al. Prostaglandins and thromboxanes. Annu Rev Biochem. 1978. https:\/\/doi.org\/10.1146\/annurev.bi.47.070178.005025.","journal-title":"Annu Rev Biochem"},{"key":"2301_CR25","doi-asserted-by":"publisher","DOI":"10.1016\/0014-5793(81)80676-x","author":"G Hansson","year":"1981","unstructured":"Hansson G, Lindgren JA, Dahl\u00e9n SE, et al. Identification and biological activity of novel omega-oxidized metabolites of leukotriene B4 from human leukocytes. FEBS Lett. 1981. https:\/\/doi.org\/10.1016\/0014-5793(81)80676-x.","journal-title":"FEBS Lett"},{"key":"2301_CR26","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.ph.44.030182.001353","author":"SI Said","year":"1982","unstructured":"Said SI. Pulmonary metabolism of prostaglandins and vasoactive peptides. Annu Rev Physiol. 1982. https:\/\/doi.org\/10.1146\/annurev.ph.44.030182.001353.","journal-title":"Annu Rev Physiol"},{"key":"2301_CR27","doi-asserted-by":"publisher","DOI":"10.1016\/0002-9343(86)90905-8","author":"F Catella","year":"1986","unstructured":"Catella F, Nowak J, Fitzgerald GA. Measurement of renal and non-renal eicosanoid synthesis. Am J Med. 1986. https:\/\/doi.org\/10.1016\/0002-9343(86)90905-8.","journal-title":"Am J Med"},{"key":"2301_CR28","doi-asserted-by":"publisher","DOI":"10.1016\/j.iac.2007.09.004","author":"N Rabinovitch","year":"2007","unstructured":"Rabinovitch N. Urinary Leukotriene E4. Immunol Allergy Clin North Am. 2007. https:\/\/doi.org\/10.1016\/j.iac.2007.09.004.","journal-title":"Immunol Allergy Clin North Am"},{"key":"2301_CR29","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M706839200","author":"WL Song","year":"2008","unstructured":"Song WL, Wang M, Ricciotti E, et al. Tetranor PGDM, an abundant urinary metabolite reflects biosynthesis of prostaglandin D2 in mice and humans. J Biol Chem. 2008. https:\/\/doi.org\/10.1074\/jbc.M706839200.","journal-title":"J Biol Chem"},{"key":"2301_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.mam.2017.03.005","author":"N Chiang","year":"2017","unstructured":"Chiang N, Serhan CN. Structural elucidation and physiologic functions of specialized pro-resolving mediators and their receptors. Mol Aspects Med. 2017. https:\/\/doi.org\/10.1016\/j.mam.2017.03.005.","journal-title":"Mol Aspects Med"},{"key":"2301_CR31","doi-asserted-by":"publisher","DOI":"10.1111\/imm.12206","author":"CD Russell","year":"2014","unstructured":"Russell CD, Schwarze J. The role of pro-resolution lipid mediators in infectious disease. Immunology. 2014. https:\/\/doi.org\/10.1111\/imm.12206.","journal-title":"Immunology"}],"container-title":["Respiratory Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02301-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12931-022-02301-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12931-022-02301-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,24]],"date-time":"2022-12-24T03:15:32Z","timestamp":1671851732000},"score":1,"resource":{"primary":{"URL":"https:\/\/respiratory-research.biomedcentral.com\/articles\/10.1186\/s12931-022-02301-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12,20]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2301"],"URL":"https:\/\/doi.org\/10.1186\/s12931-022-02301-5","relation":{},"ISSN":["1465-993X"],"issn-type":[{"value":"1465-993X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,12,20]]},"assertion":[{"value":"27 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the ethical committee of the hospital (Ethics committee Milano Area 2, Fondazione IRCCS Ca\u2019 Granda Ospedale Maggiore Policlinico, 255_2020) and all subjects provided written informed consent to participate.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"L.T., P.R., C.P., M.L.S, S.T., F.A., A.G., C.A., P.M., have no competing interest. A.S. reports grants from Chiesi, and personal fees from Chiesi and Boheringer Ingelheim. S.A. reports grants from INSMED, Chiesi and Fisher & Paykel; personal fees from McGRAW HILL, INSMED, ZAMBON, AstraZeneca, CSL Behring GmbH, Grifols, Fondazione Charta, Boehringer Ingelheim, Chiesi, ZCUBE, Menarini and GlaxoSmithKline. F.B. reports grant from Astrazeneca, Chiesi and INSMED; personal fees from Menarini, Astrazeneca, Chiesi, GSK, Guidotti, Grifols, INSMED, Novartis, Viatris, Vertex and Zambon.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"363"}}